A simultaneous increase in NKG2A+ and decrease in NKG2C+ subsets of CD56dim NK cells was observed in recipients diagnosed with chronic GvHD and in patients with EBV reactivation. This evidence concerns the gene KLRC2 and chronic graft versus host disease.